Johnson & Johnson, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 27 June 2013
Johnson & Johnson, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 26 June 2013
Endo Pharmaceuticals, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 26 June 2013
Galderma, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 26 June 2013
Grifols, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 26 June 2013
Shionogi, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 26 June 2013
Hospira, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 18 June 2013
Kyowa Hakko Kirin, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 18 June 2013
Warner Chilcott, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 14 June 2013
Boehringer Ingelheim, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years
Posted on 14 June 2013
Lundbeck, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years